Health

About 3 in 4 Pennsylvanians will still qualify for some tax credits, but the amounts will, on average, be smaller. Others face paying for plans at full price.

The mission of the campaign is to spread educational messaging and conversation points about heart health and what additional factors lead to risk conditions.

New York Times investigative reporter Sarah Kliff explains how electronic fetal monitoring is driving up C-section rates.

The legislation would require employers to provide reasonable accommodations for disruptive symptoms of menstruation and menopause.

The warning is precautionary; the health department said it believes there is no threat to the public.

Health officials are investigating 13 cases in Pennsylvania, New Jersey and eight other states. ByHeart Inc. agreed to recall two lots of its Whole Nutrition Infant Formula.

Nonprofits say it is common for owners to supplement their pet’s diet with human food purchased using Supplemental Nutrition Assistance benefits.

On this Veterans Day episode, we explore healing after combat — from a psychedelic treatment in Mexico to making ceramic mugs.

Certified menopause doctors say elinzanetant, a nonhormonal drug for hot flashes, could be a new option for women who can’t take hormone treatment therapies.

Congress remains deadlocked over extending federal health insurance subsidies and Pennsylvania makes contingency plans for disruption in the marketplace later.

Americans shopping for Affordable Care Act insurance are in for some sticker shock. Premiums are set to rise by nearly 30% on average; unless the congress extends tax credits.

Health systems and insurance companies are using artificial intelligence to analyze CT scans and MRIs, update electronic health records and review coverage decisions.

Coca-Cola’s rise to global brand domination, and how the company influenced our habits and perceptions along the way.

Hospital workers and public health officials say new combinations of street drugs, traumatic brain injuries and other health issues could be driving the uptick in seizures.

Pregnant and lactating women have been historically excluded from drug trials, even though many rely on medications to manage pain, mental health and chronic disease.